May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Persistent Elevation of Intraocular Pressure after Intravitreal Injection of Triamcinolone Acetonide
Author Affiliations & Notes
  • J.S. Sarkar
    Retina Associates of New York, New York, NY
  • B.Z. Cohen
    Retina Associates of New York, New York, NY
  • K.J. Wald
    Retina Associates of New York, New York, NY
  • J.C. Paccione
    Retina Associates of New York, New York, NY
  • Footnotes
    Commercial Relationships  J.S. Sarkar, None; B.Z. Cohen, None; K.J. Wald, None; J.C. Paccione, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4086. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.S. Sarkar, B.Z. Cohen, K.J. Wald, J.C. Paccione; Persistent Elevation of Intraocular Pressure after Intravitreal Injection of Triamcinolone Acetonide . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4086.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To study the occurrence of both transient as well as persistent elevation of intraocular pressure (IOP) following intravitreal injection of triamcinolone acetonide (IVT). Methods: We retrospectively reviewed medical records of 100 patients ( 125 eyes). These patients were treated with 4mg (0.1 ml) of IVT for macular edema secondary to diabetic retinopathy, retinal vascular occlusion and pseudophakia. Follow up period was between 9 – 12 months. Results: Baseline IOP was 15 +/– 3 mm Hg. 15/125 (12 %) of injected eyes had an increase of IOP (range, 22– 38 mm Hg). IOP elevation occured after a period of 4 +/– 2 weeks of injection.Of these, 12 eyes (9.6%) had a transient increase in IOP which returned to baseline within 3–4 months. During this period the IOP was controlled with topical medication. The remaining 3 eyes (2.4%) had a persistently elevated IOP requiring topical medication for more than 6 months. There were no signs of inflammation in the anterior segment of these 3 eyes. None of these 3 patients had a previous or family history of glaucoma. Conclusions: IOP elevation post IVT is transient in the majority of patients however persistent elevation can occur uncommonly.

Keywords: intraocular pressure • drug toxicity/drug effects • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×